VALINK Trademark
Trademark Overview
On Tuesday, March 5, 2024, a trademark application was filed for VALINK with the United States Patent and Trademark Office. The USPTO has given the VALINK trademark a serial number of 79397717. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, October 15, 2024. This trademark is owned by Valink Therapeutics Inc.. The VALINK trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceuticals, medical and veterinary preparations; pharmaceutical drugs; pharmaceutical preparations; pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; anti-cancer drugs; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of tumours; chemotherapeutics; biotechnological preparations for medical use; antibodies.
Chemicals for use in industry and science; biological preparations for use in industry and science; proteins for use in science; proteins for use in industry; proteins for detecting antibodies [other than for medical use]; proteins for binding antibodies [other than for medical use]; immunological antibodies, other than for medical use; chemical substances for use in the biotechnological industry; chemicals for use in the pharmaceutical industry; chemical substances for use in the production of drugs; chemicals for use in scientific research [other than medical or veterinary]; chemicals for use in biotechnological product development.
Scientific and technological services and research and design relating thereto; biotechnology research; biological research, clinical research and medical research; scientific research for medical purposes; research and development of vaccines and medicines; scientific research for medical purposes in the area of cancerous diseases; research and development services in the field of antibodies; research and development in the pharmaceutical and biotechnology fields; biotechnology testing; research relating to biotechnology; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; development of pharmaceutical preparations and medicines; pharmaceutical research and development; research and development for the pharmaceutical industry; conducting clinical trials for pharmaceutical products; testing of pharmaceuticals; biochemistry drug services; biochemistry consultancy; biochemistry research services; biochemical research and development; re...
General Information
Serial Number | 79397717 |
Word Mark | VALINK |
Filing Date | Tuesday, March 5, 2024 |
Status | 641 - NON-FINAL ACTION - MAILED |
Status Date | Tuesday, October 15, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Pharmaceuticals, medical and veterinary preparations; pharmaceutical drugs; pharmaceutical preparations; pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; anti-cancer drugs; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of tumours; chemotherapeutics; biotechnological preparations for medical use; antibodies. |
Goods and Services | Chemicals for use in industry and science; biological preparations for use in industry and science; proteins for use in science; proteins for use in industry; proteins for detecting antibodies [other than for medical use]; proteins for binding antibodies [other than for medical use]; immunological antibodies, other than for medical use; chemical substances for use in the biotechnological industry; chemicals for use in the pharmaceutical industry; chemical substances for use in the production of drugs; chemicals for use in scientific research [other than medical or veterinary]; chemicals for use in biotechnological product development. |
Goods and Services | Scientific and technological services and research and design relating thereto; biotechnology research; biological research, clinical research and medical research; scientific research for medical purposes; research and development of vaccines and medicines; scientific research for medical purposes in the area of cancerous diseases; research and development services in the field of antibodies; research and development in the pharmaceutical and biotechnology fields; biotechnology testing; research relating to biotechnology; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; development of pharmaceutical preparations and medicines; pharmaceutical research and development; research and development for the pharmaceutical industry; conducting clinical trials for pharmaceutical products; testing of pharmaceuticals; biochemistry drug services; biochemistry consultancy; biochemistry research services; biochemical research and development; research and development in the field of biotechnology; biochemical engineering services; laboratory services; medical research laboratory services; medical laboratories; providing information relating to scientific research in the fields of biochemistry and biotechnology; consultancy in the field of pharmaceutical research; consultancy in the field of biotechnology; consultancy relating to research and development in the field of therapeutics. |
Classification Information
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, June 20, 2024 |
Primary Code | 001 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, June 20, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, June 20, 2024 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Valink Therapeutics Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | US |
Trademark Events
Event Date | Event Description |
Thursday, June 20, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Friday, June 21, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, October 10, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Tuesday, October 15, 2024 | REFUSAL PROCESSED BY MPU |
Tuesday, October 29, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Sunday, November 17, 2024 | REFUSAL PROCESSED BY IB |
Friday, June 21, 2024 | APPLICATION FILING RECEIPT MAILED |
Wednesday, September 18, 2024 | ASSIGNED TO EXAMINER |
Wednesday, October 9, 2024 | NON-FINAL ACTION WRITTEN |